Mounjaro is not suitable if you are: Pregnant or planning to become pregnant (stop Mounjaro at least one month before trying to conceive) Allergic to tirzepatide or any other ingredient in Mounjaro Have certain medical conditions, such as severe digestive problems, a history of pancreatitis, or thyroid cancer, or if you use specific diabetes medications
Tirzepatide (Mounjaro) is a highly effective weight loss treatment for individuals with a body mass index (BMI) of 30 or above, or those with a BMI of 27 or higher who also have conditions like type 2 diabetes, high blood pressure, or elevated cholesterol levels
Follow for More Ammad Ali Shahid #Digoxin #Furosemide #DrugInteraction #DigoxinToxicity #Pharmacology #PharmacyLife #MedicalEducation #ClinicalPharmacy #Cardiology #Medicine #PharmaStudents #DrugSafety #Healthcare #MedEd #AmmadAliShahid To view or add a comment, sign in On May 18, 2026, the FDA approved baxdrostat as the first aldosterone synthase inhibitor for adults with uncontrolled hypertension on two or more agents
This does not mean they are inherently dangerous, but it does mean you need to choose your provider carefully
However, this data comes from observational studies, not randomized controlled trials, so it should be interpreted cautiously
Community chat, opt-in leaderboards, and fair tournament rules make it easier to enjoy competition without pressure
